Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

The U.S. District Court for the Eastern District of Pennsylvania concluded the plaintiff, who has Type 1 diabetes and tracks ...

The integration of wearable technology into healthcare has transformed how individuals monitor their health and manage ...

A growing number of women experience high blood sugar levels during pregnancy which typically resolve after birth.

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

According to the study, cannabinoids showed stronger binding affinities to these enzymes compared to some standard diabetes drugs, with the exception of DPP-4 inhibitors. THC and CBN demonstrated ...

The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical ...

The U.S. Food and Drug Administration (US FDA) has said patients using diabetes devices that rely on smartphones ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Continuous glucose monitors are small devices that use a sensor under the skin to measure blood sugar, sending regular ...